US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases: Hamburg, Germany Thursday, January 23, 2025, 10:00 Hrs [IST] Evotec SE, ...

Telangana DCA raids de-addiction centre at Hanumakonda & seizes huge quantities of drugs stocked without licence: Peethaambaran Kunnathoor, Chennai Thursday, January 23, 2025, 08: ...

Indian pharma exudes confidence to sustain US market presence under President Trump’s regime: Nandita Vijayasimha, Bengaluru Thursday, January 23, 2025, 08:00 Hrs [IST] Indian p ...

ADMI expects tax incentives, regulatory reforms & rationalisation of GST from Union Budget 2025: Our Bureau, New Delhi Thursday, January 23, 2025, 08:00 Hrs [IST] The medical devi ...

NPPA calls for price data on diagnostic agent iohexol following DoP's review order: Gireesh Babu, New Delhi Thursday, January 23, 2025, 08:00 Hrs [IST] The National Pharmaceutical ...

CDSCO seeks urgent industry inputs on regulatory challenges and innovation in pharma: Shardul Nautiyal, Mumbai Thursday, January 23, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...

Poxel receives Chinese patent for use of Imeglimin for type-2 diabetic patients with renal impairment: Lyon, France Wednesday, January 22, 2025, 18:00 Hrs [IST] Poxel SA, a clinic ...

Strides Pharma debuts with a stellar ESG rating of 76/100 in the S&P Global’s Corporate Sustainability Assessment: Our Bureau, Bengaluru Wednesday, January 22, 2025, 13:40 Hrs [ ...

DKSH expands exclusive partnership with Hygiena, a global leader in food safety and health diagnostics, to include Malaysia: Camarillo, California Wednesday, January 22, 2025, 17: ...

Nanobiotix begins patient dosing in new randomized phase 2 study of JNJ-1900 for patients with stage 3 unresectable NSCLC: Paris Wednesday, January 22, 2025, 13:00 Hrs [IST] Nanob ...

Ascletis announces positive results from US phase Ia SAD study of small molecule oral GLP-1R agonist ASC30 in patients with obesity: Hong Kong, China Wednesday, January 22, 2025, ...